Joana Alexandria Ferreira Dias

ORCID: 0000-0001-9435-2303
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatologic Treatments and Research
  • Drug-Induced Adverse Reactions
  • melanin and skin pigmentation
  • Autoimmune Bullous Skin Diseases
  • Skin Protection and Aging
  • Ocular Oncology and Treatments
  • Acne and Rosacea Treatments and Effects
  • Facial Rejuvenation and Surgery Techniques
  • Nonmelanoma Skin Cancer Studies
  • Migraine and Headache Studies
  • Pharmaceutical studies and practices
  • Laser Applications in Dentistry and Medicine
  • Polyomavirus and related diseases
  • Hair Growth and Disorders
  • Urticaria and Related Conditions
  • Skin Diseases and Diabetes
  • Biomedical Research and Pathophysiology
  • Facial Nerve Paralysis Treatment and Research

Universidade Estadual Paulista (Unesp)
2021-2022

Universidade Federal de São Paulo
2022

Melasma can be refractory to treatment, and relapses are frequent. Thiamidol is a new potent tyrosinase inhibitor that has been found effective as cosmeceutical for the depigmenting of melasma.This study compared efficacy tolerability topical 0.2% vs. 4% hydroquinone facial melasma.Fifty women with melasma participated in randomized, evaluator-blinded, controlled from September through November 2020. Patients were randomly assigned apply double layer twice day or cream at bedtime, 90 days....

10.1111/jdv.17344 article EN Journal of the European Academy of Dermatology and Venereology 2021-05-14

Abstract Objective To assess the efficacy and safety of topical 5% cysteamine versus 4% hydroquinone in treatment facial melasma women. Topical is an antioxidant tyrosinase inhibitor that has been shown to be effective melasma. However, date, no study compared performance for Methods A quasi‐randomized, multicenter, evaluator‐blinded clinical trial was conducted on 40 women with who were submitted nightly application (CYS) or (HQ) hyperpigmented areas 120 days. Both groups required use...

10.1111/ijd.15146 article EN International Journal of Dermatology 2020-08-31

Melasma can be recalcitrant to treatment, and relapses are common. Pycnogenol has been reported effective in treating melasma.To compare the efficacy, safety tolerability of 75 mg pycnogenol taken orally twice a day vs. placebo, association with triple combination broad-spectrum sunscreen for treatment facial melasma.A randomized, double-blind, parallel, placebo-controlled study was conducted on 44 women melasma single centre from May 2019 through November 2019. Patients were randomly...

10.1111/jdv.16896 article EN Journal of the European Academy of Dermatology and Venereology 2020-08-26

LETTERcircumscribed erythema in the V-neck area not protected by clothes during season when dose of ultraviolet radiation is increased Japan, which was considered to be a photo-Koebner phenomenon.Only several cases photo-induced or photo-distributed SS have been reported, both A and B were candidates for induction skin lesions. 1---3Although phototesting performed present case, patient had no previous history photosensitive dermatitis taking drugs that can induce eruptions.To our knowledge,...

10.1016/j.abd.2020.09.017 article EN cc-by Anais Brasileiros de Dermatologia 2022-01-15

Estudo piloto sobre a eficácia e segurança do uso da cisteamina 5% como terapia de contato por toda noite no tratamento melasma facial Efficacy and safety of the

10.5935/scd1984-8773.2022140160 article PT cc-by Surgical & Cosmetic Dermatology 2022-01-01
Coming Soon ...